VEGFA and neoplasm: In murine models of pancreatic neuroendocrine carcinoma and glioblastoma, angiogenesis inhibitors targeting the VEGF pathway have been shown to partially inhibit tumour growth, while causing increased invasiveness and elevated metastasis [30].